John A. Katzenellenbogen, Christopher G. Mayne, Benita S. Katzenellenbogen,
Geoffrey L. Greene, and Sarat Chandarlapaty.
Structural underpinnings of oestrogen receptor mutations in endocrine
therapy resistance.
Nature Reviews Cancer, 18:377-388, 2018.
(PMC: PMC6252060)
KATZ2018-CM
Oestrogen receptor- (ER), a key driver of breast cancer,
normally requires oestrogen for activation. Mutations that constitutively
activate ER without the need for hormone binding are frequently
found in endocrine-therapy-resistant breast cancer metastases and are
associated with poor patient outcomes. The location of these mutations in
the ER ligand-binding domain and their impact on receptor conformation
suggest that they subvert distinct mechanisms that normally maintain the
low basal state of wild-type ER in the absence of hormone. Such
mutations provide opportunities to probe fundamental issues underlying
ligand-mediated control of ER activity. Instructive contrasts
between these ER mutations and those that arise in the androgen
receptor (AR) during anti-androgen treatment of prostate cancer highlight
differences in how activation functions in ERs and AR control receptor
activity, how hormonal pressures (deprivation versus antagonism) drive the
selection of phenotypically different mutants, how altered protein
conformations can reduce antagonist potency and how altered ligand–
receptor contacts can invert the response that a receptor has to an agonist
ligand versus an antagonist ligand. A deeper understanding of how ligand
regulation of receptor conformation is linked to receptor function offers a
conceptual framework for developing new anti-oestrogens that might be
more effective in preventing and treating breast cancer.
Download Full Text
The manuscripts available on our site are provided for your personal
use only and may not be retransmitted or redistributed without written
permissions from the paper's publisher and author. You may not upload any
of this site's material to any public server, on-line service, network, or
bulletin board without prior written permission from the publisher and
author. You may not make copies for any commercial purpose. Reproduction
or storage of materials retrieved from this web site is subject to the
U.S. Copyright Act of 1976, Title 17 U.S.C.